California Cryobank (CCB), a global provider of reproductive tissue donor services and storage and stem cell banking, has been acquired by equity investors Longitude Venture Partners II, L.P. and NovaQuest Pharma Opportunities Fund III, L.P.
The acquisition of CCB was financed through a combination of equity contributed by Longitude and NovaQuest and debt provided by Golub Capital. The amount of the transaction was not disclosed.
Founded in 1977 by Dr. Charles Sims and Dr. Cappy Rothman, California Cryobank has built a global presence in both fertility and cellular therapy. Its Reproductive Division is a large provider of anonymous donor sperm services and private reproductive tissue storage while its Stem Cell Division is one of the most active stem cell banking businesses in the world.
The company operates throughout the United States, as well as Europe, South America and Asia. It is registered with the FDA, accredited by the AATB (American Association of Tissue Banks), licensed by the states of California and New York, and has a CLIA licensed clinical laboratory.